TY - JOUR AU - Schmelzle, T. AU - Hall, M. PY - 2000 DA - 2000// TI - TOR, a central controller of cell growth JO - Cell VL - 103 UR - https://doi.org/10.1016/S0092-8674(00)00117-3 DO - 10.1016/S0092-8674(00)00117-3 ID - Schmelzle2000 ER - TY - JOUR AU - Jefferies, H. AU - Fumagalli, S. AU - Dennis, P. B. PY - 1997 DA - 1997// TI - Rapamycin suppresses 5' TOP mRNA translation through inhibition of p70s6k JO - EMBO J VL - 16 UR - https://doi.org/10.1093/emboj/16.12.3693 DO - 10.1093/emboj/16.12.3693 ID - Jefferies1997 ER - TY - JOUR AU - Gingras, A. AU - Gygi, S. AU - Raught, B. PY - 1999 DA - 1999// TI - Regulation of 4E-BP1 phosphorylation: a novel two-step mechanism JO - Genes Dev VL - 13 UR - https://doi.org/10.1101/gad.13.11.1422 DO - 10.1101/gad.13.11.1422 ID - Gingras1999 ER - TY - JOUR AU - Vivanco, I. AU - Sawyers, C. PY - 2002 DA - 2002// TI - The phosphatidylinositol 3-kinase AKT pathway in human cancer JO - Nat Rev Cancer VL - 2 UR - https://doi.org/10.1038/nrc839 DO - 10.1038/nrc839 ID - Vivanco2002 ER - TY - JOUR AU - Di Cosimo, S. AU - Seoane, J. AU - Guzman, M. PY - 2005 DA - 2005// TI - Combination of the mammalian target of rapamycin (mTOR) inhibitor everolimus (E) with the insulin like growth factor-1-receptor (IGF-1-R) inhibitor NVP-AEW-541: a mechanistic based anti-tumor strategy JO - J Clin Oncol VL - 23 ID - Di Cosimo2005 ER - TY - JOUR AU - Di Cosimo, S. AU - Scaltriti, M. AU - Val, D. PY - 2007 DA - 2007// TI - The PI3-K/AKT/mTOR pathway as a target for breast cancer therapy JO - J Clin Oncol VL - 25 ID - Di Cosimo2007 ER - TY - JOUR AU - Carracedo, A. AU - Ma, L. AU - Teruya-Feldstein, J. PY - 2008 DA - 2008// TI - Inhibition of mTORC1 leads to MAPK pathway activation through a PI3K-dependent feedback loop in human cancer JO - J Clin Invest VL - 118 ID - Carracedo2008 ER - TY - JOUR AU - Sarbassov, D. D. AU - Ali, S. M. AU - Sengupta, S. PY - 2006 DA - 2006// TI - Prolonged rapamycin treatment inhibits mTORC2 assembly and Akt/PKB JO - Mol Cell VL - 22 UR - https://doi.org/10.1016/j.molcel.2006.03.029 DO - 10.1016/j.molcel.2006.03.029 ID - Sarbassov2006 ER - TY - JOUR AU - Stemke-Hale, K. AU - Gonzalez-Angulo, A. M. AU - Lluch, A. PY - 2008 DA - 2008// TI - An integrative genomic and proteomic analysis of PIK3CA, PTEN, and AKT mutations in breast cancer JO - Cancer Res VL - 68 UR - https://doi.org/10.1158/0008-5472.CAN-07-6854 DO - 10.1158/0008-5472.CAN-07-6854 ID - Stemke-Hale2008 ER - TY - CHAP AU - Markman, B. AU - Atzori, F. AU - Pérez-García, J. PY - 2009 DA - 2009// TI - Status of PI3K inhibition and biomarker development in cancer therapeutics BT - Ann Oncol ID - Markman2009 ER - TY - JOUR AU - Tabernero, J. AU - Rojo, F. AU - Calvo, E. PY - 2008 DA - 2008// TI - Dose - and schedule-dependent inhibition of the mammalian target of rapamycin pathway with everolimus: a phase I tumor pharmacodynamic study in patients with advanced solid tumors JO - J Clin Oncol VL - 26 UR - https://doi.org/10.1200/JCO.2007.14.5482 DO - 10.1200/JCO.2007.14.5482 ID - Tabernero2008 ER - TY - JOUR AU - Ellard, S. L. AU - Clemons, M. AU - Gelmon, K. A. PY - 2009 DA - 2009// TI - Randomized phase II study comparing two schedules of everolimus in patients with recurrent/metastatic breast cancer: NCIC Clinical Trials Group IND.163 JO - J Clin Oncol VL - 27 UR - https://doi.org/10.1200/JCO.2008.21.3033 DO - 10.1200/JCO.2008.21.3033 ID - Ellard2009 ER - TY - JOUR AU - Baselga, J. AU - Semiglazov, V. AU - van Dam, P. PY - 2009 DA - 2009// TI - Phase II randomized study of neoadjuvant everolimus plus letrozole compared with placebo plus letrozole in patients with estrogen receptor-positive breast cancer JO - J Clin Oncol VL - 27 UR - https://doi.org/10.1200/JCO.2008.18.8391 DO - 10.1200/JCO.2008.18.8391 ID - Baselga2009 ER - TY - JOUR AU - Baselga, J. AU - Fumoleau, P. AU - Gil, M. PY - 2004 DA - 2004// TI - Phase II, 3 arm study of CCI-779 in combination with letrozole in postmenopausal women with locally advanced or metastatic breast cancer. Preliminary results JO - J Clin Oncol VL - 22 ID - Baselga2004 ER - TY - JOUR AU - Chow, L. W. S. AU - Sun, Y. AU - Jassem, J. PY - 2006 DA - 2006// TI - Phase 3 study of temsirolimus with letrozole or letrozole alone in postmenopausal women with locally advanced or metastatic breast cancer JO - Breast Cancer Res Treat VL - 100 ID - Chow2006 ER - TY - JOUR AU - André, F. AU - Campone, M. AU - Hurvitz, S. A. PY - 2008 DA - 2008// TI - Multicenter phase I clinical trial of daily and weekly RAD001 in combination with weekly paclitaxel and trastuzumab in patients with HER2-overex-pressing metastatic breast cancer with prior resistance to trastuzumab JO - J Clin Oncol VL - 26 ID - André2008 ER -